Study on the Relationship between Cervical Cancer and p53 Codon 72 Polymorphism

Journal of West China University of Medical Sciences

Volumn 33, Issue 2, 2002, Pages 274-275

  Qie, Mingrong ^a   Zhang, Yanhua ^b   Wu, Junmel ^b  

^a SICHUAN UNIVERSITY   (China)

^b NONE

Author keywords

Cervical cancer; p53 codon 72 polymorphism

Indexed keywords

ARGININE; PROLINE;

ALLELE; ARTICLE; CODON; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HOMOZYGOTE; HUMAN; TUMOR SUPPRESSOR GENE; UTERINE CERVIX TUMOR;

ALLELES; ARGININE; CODON; FEMALE; GENES, P53; GENOTYPE; HOMOZYGOTE; HUMANS; POLYMORPHISM, GENETIC; PROLINE; UTERINE CERVICAL NEOPLASMS;

EID: 0038048858     PISSN: 02577712     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Storey A, Thomas M, Kalita A, et al. Role of a p53 Polymorphism in the development of human papillomavirus-associated cancer. Nature, 1998; 393(21):229
2. Adam NR, Andy R, RM Al-Jehani, et al. p53 codon 72 Polymorphism and risk of cervical cancer in UK. The Lancet, 1998; 352:871
3. Beckman G, Birgander R, Sjalander A, et al. Is p53 Polymorphism maintained by natural selection. Hum Hered, 1994; 44:266
4. Dela, Fabregat V, Romero M, et al. Polymorphism of the p53 gene. Nucl Acid Res, 1990; 18:4963
5. Scheffiner M, Werness BA, levine AJ, et al. The E6 oncoprotein encoded by human papillomavirus type 16 and 18 promotes the degradation of p53. Cell, 1990; 63:1129